NCT00049387View on ClinicalTrials.gov

Tipifarnib, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma

PHASE1CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

September 30, 2002

Primary Completion Date

June 30, 2007

Study Completion Date

June 30, 2007

Conditions
Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma
Interventions
DRUG

tipifarnib

Given PO

DRUG

temozolomide

Given PO

RADIATION

radiation therapy

Undergo partial brain radiation therapy

Trial Locations (1)

21231-1000

Adult Brain Tumor Consortium, Baltimore

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00049387 - Tipifarnib, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma | Biotech Hunter | Biotech Hunter